» Articles » PMID: 38254165

Targeted Long-read Sequencing Identified a Causal Structural Variant in X-linked Nephrogenic Diabetes Insipidus

Overview
Publisher Biomed Central
Specialty Genetics
Date 2024 Jan 23
PMID 38254165
Authors
Affiliations
Soon will be listed here.
Abstract

Background: X-linked nephrogenic diabetes insipidus (NDI) is a rare genetic renal disease caused by pathogenic variants in the AVPR2 gene. Single nucleotide variants and small insertions/deletions in AVPR2 are reliably detected by routine clinical sequencing. Nevertheless, structural variants involving AVPR2 are challenging to identify accurately by conventional genetic testing. Here, we report a novel deletion of AVPR2 in a Czech family identified for the first time by targeted long-read sequencing (T-LRS).

Methods: A male proband with X-linked NDI underwent clinical sequencing of the AVPR2 gene that failed and thus indicated possible whole-gene deletion. Therefore, PCR mapping and subsequent targeted long-read sequencing (T-LRS) using a Pacific Biosciences sequencer were applied to search for the suspected deletion. To validate the deletion breakpoints and prove variant segregation in the family with X-linked NDI, Sanger sequencing of the deletion junction was performed. Quantitative real-time PCR was further carried out to confirm the carrier status of heterozygous females.

Results: By T-LRS, a novel 7.5 kb deletion of AVPR2 causing X-linked NDI in the proband was precisely identified. Sanger sequencing of the deletion junction confirmed the variant breakpoints and detected the deletion in the probands´ mother, maternal aunt, and maternal cousin with X-linked NDI. The carrier status in heterozygous females was further validated by quantitative real-time PCR.

Conclusions: Identifying the 7.5 kb deletion gave a precise molecular diagnosis for the proband, enabled genetic counselling and genetic testing for the family, and further expanded the spectrum of structural variants causing X-linked NDI. Our results also show that T-LRS has significant potential for accurately identifying putative structural variants.

Citing Articles

The Third-Generation Sequencing Challenge: Novel Insights for the Omic Sciences.

Scarano C, Veneruso I, De Simone R, Di Bonito G, Secondino A, DArgenio V Biomolecules. 2024; 14(5).

PMID: 38785975 PMC: 11117673. DOI: 10.3390/biom14050568.

References
1.
Dong Y, Sheng H, Chen X, Yin J, Su Q . Deletion of the V2 vasopressin receptor gene in two Chinese patients with nephrogenic diabetes insipidus. BMC Genet. 2006; 7:53. PMC: 1657029. DOI: 10.1186/1471-2156-7-53. View

2.
Kotnik P, Battelino T, Debeljak M, Trebusak Podkrajsek K, Waldhauser F, Frokiaer J . Correlation between AVPR2 mutations and urinary AQP2 excretion in patients with nephrogenic diabetes insipidus. J Pediatr Endocrinol Metab. 2007; 20(4):483-9. DOI: 10.1515/jpem.2007.20.4.483. View

3.
Carroll P, Al-Mojalli H, Al-Abbad A, Al-Hassoun I, Al-Hamed M, Al-Amr R . Novel mutations underlying nephrogenic diabetes insipidus in Arab families. Genet Med. 2006; 8(7):443-7. DOI: 10.1097/01.gim.0000223554.46981.7a. View

4.
Merker J, Wenger A, Sneddon T, Grove M, Zappala Z, Fresard L . Long-read genome sequencing identifies causal structural variation in a Mendelian disease. Genet Med. 2017; 20(1):159-163. PMC: 5741540. DOI: 10.1038/gim.2017.86. View

5.
Fujimoto M, Imai K, Hirata K, Kashiwagi R, Morinishi Y, Kitazawa K . Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes. BMC Med Genet. 2008; 9:42. PMC: 2413213. DOI: 10.1186/1471-2350-9-42. View